SALINAS, Calif., June 4, 2013—Next Pharmaceuticals acquired the distribution rights, patents, trademarks and scientific knowledge for Sytrinol from KGK Synergize.
Press Releases
Next Pharmaceuticals Acquires Sytrinol
You might be interested in:
-
Press Releases
KGK Science Partners with Zentrela to Test Ontario Government-Funded Cannabis Impairment Device
-
Press Releases
KGK Science CEO Joins Natural Products Canada Board of Directors
-
Press Releases
KGK Science Leads the Nutraceutical Industry into a New Era of Scientific and Statistical Concepts